For example, Yu et al. revealed that inhibiting the activation of naïve CD4+ T cells and Th1/Th17 cell differentiation by blocking glutaminolysis play a therapeutic role in autoimmune hepatitis (Yu et al., 2022). Here, CD4 is linked to autoimmune hepatitis.